Literature DB >> 20657344

Asymptomatic norovirus infections in Nicaraguan children and its association with viral properties and histo-blood group antigens.

Filemon Bucardo1, Johan Nordgren, Beatrice Carlsson, Elin Kindberg, Margarita Paniagua, Roland Möllby, Lennart Svensson.   

Abstract

BACKGROUND: It has been previously reported that histo-blood group antigens (HBGAs) and particularly secretor status provides protection against symptomatic norovirus infection, but it remains unclear to what extent this includes asymptomatic infections in children.
METHODS: To explore whether HBGAs or certain viral genotypes are associated with asymptomatic norovirus infections in a pediatric population in Nicaragua, we investigated 163 children ≤5 years of age, without a recent history of diarrhea (≤10 days).
RESULTS: Asymptomatic norovirus infections were observed in 11.7% (19/163), with children ≤6 months of age being most frequently infected (16%). Of the 19 norovirus-positive children, 4 (21%) and 10 (53%) were infected with genogroups GI and GII, respectively, and 4 children (21%) were infected with viruses of both genogroups. Most children had ≥10 viral genomes per gram of feces. Nucleotide sequence analysis (15/19) revealed uncommon genotypes, such as, GII.7 (n = 5) and GII.2 (n = 3). An interesting observation was the low frequency of norovirus GII.4 strains among the asymptomatic children. AB blood type, Lewis a (Le) phenotype and nonsecretor genotype (sese) were not found among the asymptomatic children, but they occurred in population controls.
CONCLUSIONS: Frequency of asymptomatic norovirus infections was similar to that observed in symptomatic children from Nicaragua. Norovirus GII.2 and GII.7 were frequently detected but the globally dominating GII.4 was infrequent. Host genetic factors previously observed to be associated with protection against symptomatic norovirus infection were not found in this study.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20657344     DOI: 10.1097/INF.0b013e3181ed9f2f

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  23 in total

Review 1.  Norovirus.

Authors:  Elizabeth Robilotti; Stan Deresinski; Benjamin A Pinsky
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

2.  Environmental Surveillance of Norovirus Genogroups I and II for Sensitive Detection of Epidemic Variants.

Authors:  Shinobu Kazama; Takayuki Miura; Yoshifumi Masago; Yoshimitsu Konta; Kentaro Tohma; Takafumi Manaka; Xiaofang Liu; Daisuke Nakayama; Takashi Tanno; Mayuko Saito; Hitoshi Oshitani; Tatsuo Omura
Journal:  Appl Environ Microbiol       Date:  2017-04-17       Impact factor: 4.792

3.  Pattern of circulation of norovirus GII strains during natural infection.

Authors:  James Ayukepi Ayukekbong; Cajetan Fobisong; Ferdinand Tah; Magnus Lindh; Theresia Nkuo-Akenji; Tomas Bergström
Journal:  J Clin Microbiol       Date:  2014-10-01       Impact factor: 5.948

Review 4.  Blood Groups in Infection and Host Susceptibility.

Authors:  Laura Cooling
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

5.  Risk Factors for Norovirus Gastroenteritis among Nicaraguan Children.

Authors:  Joann F Gruber; Natalie M Bowman; Sylvia Becker-Dreps; Yaoska Reyes; Connor Belson; Kenan C Michaels; Filemon Bucardo
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

6.  Lacto-N-tetraose, fucosylation, and secretor status are highly variable in human milk oligosaccharides from women delivering preterm.

Authors:  Maria Lorna A De Leoz; Stephanie C Gaerlan; John S Strum; Lauren M Dimapasoc; Majid Mirmiran; Daniel J Tancredi; Jennifer T Smilowitz; Karen M Kalanetra; David A Mills; J Bruce German; Carlito B Lebrilla; Mark A Underwood
Journal:  J Proteome Res       Date:  2012-08-28       Impact factor: 4.466

7.  Antiviral activity of nucleoside analogues against norovirus.

Authors:  Verónica P Costantini; Tony Whitaker; Leslie Barclay; David Lee; Tamara R McBrayer; Raymond F Schinazi; Jan Vinjé
Journal:  Antivir Ther       Date:  2012-08-14

8.  Pediatric norovirus GII.4 infections in Nicaragua, 1999-2015.

Authors:  Filemón Bucardo; Yaoska Reyes; Sylvia Becker-Dreps; Natalie Bowman; Joann F Gruber; Jan Vinjé; Felix Espinoza; Margarita Paniagua; Angel Balmaseda; Lennart Svensson; Johan Nordgren
Journal:  Infect Genet Evol       Date:  2017-10-02       Impact factor: 3.342

9.  Prevalence and genetic diversity of viral gastroenteritis viruses in children younger than 5 years of age in Guatemala, 2014-2015.

Authors:  Marta Diez-Valcarce; Maria Renee Lopez; Beatriz Lopez; Oneida Morales; Manuel Sagastume; Loren Cadena; Susan Kaydos-Daniels; Claudia Jarquin; John P McCracken; Joe P Bryan; Jan Vinjé
Journal:  J Clin Virol       Date:  2019-03-09       Impact factor: 3.168

10.  Can Use of Viral Load Improve Norovirus Clinical Diagnosis and Disease Attribution?

Authors:  Kayoko Shioda; Leslie Barclay; Sylvia Becker-Dreps; Filemon Bucardo-Rivera; Philip J Cooper; Daniel C Payne; Jan Vinjé; Benjamin A Lopman
Journal:  Open Forum Infect Dis       Date:  2017-08-03       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.